Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 169.92
+0.15 (0.09%)
Sep 30, 2025, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 15.09 billion as of October 6, 2025. Its market cap has increased by 589.35% in one year.
Market Cap
15.09B
Enterprise Value
14.04B
Revenue
466.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
169.92
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 15.09B, an increase of 242.35%. That is a compound annual growth rate of 22.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 15.09B | 172.48% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | 2.43B | 10.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |